The Morning Risk Report
Wall Street Journal
Biden administration bans U.S. sales of Kaspersky software, and banks are pressed to screen for money flow from fentanyl precursors. Also, Eli Lilly files more lawsuits at sellers of counterfeit Mounjaro, Zepbound.